<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00757458</url>
  </required_header>
  <id_info>
    <org_study_id>EDTA-652</org_study_id>
    <nct_id>NCT00757458</nct_id>
  </id_info>
  <brief_title>Evaluation of Bacterial and Fungal Contamination During Propofol Continuous Infusion</brief_title>
  <official_title>Evaluation of Bacterial and Fungal Contamination During Propofol Continuous Infusion in Patients Undergoing General Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to verify the existence of bacterial and/or fungal contamination
      during different technics of propofol with or without EDTA continuous infusion in patients
      undergoing general anesthesia.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>December 2008</start_date>
  <completion_date type="Anticipated">December 2009</completion_date>
  <primary_completion_date type="Anticipated">June 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Existence of bacterial and/or fungal contamination during different technics of propofol continuous infusion</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">652</enrollment>
  <condition>Drug Contamination</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>TCI with EDTA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Re-filling of propofol syringe (Diprivan®-Astra Zeneca) with propofol containing EDTA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Re-filling of propofol syringe (Diprivan®-Astra Zeneca) with propofol without EDTA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Target controlled infusion of propofol without EDTA</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>EDTA without re-filling</intervention_name>
    <description>Target controlled infusion of propofol containing EDTA (Diprivan®-Astra Zeneca) using equipment Diprifusor® (Astra Zeneca), without re-filling of syringe.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Propofol syringe re-filling with propofol containing EDTA</intervention_name>
    <description>Target controlled infusion of propofol (Diprivan®-Astra Zeneca) using equipment Diprifusor® (Astra Zeneca) with re-filling of syringe with propofol containing EDTA.</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Target controlled infusion of propofol without EDTA</intervention_name>
    <description>Target controlled infusion of propofol without EDTA using Marshal´s technic with Alaris® or Fresenius® equipment</description>
    <arm_group_label>4</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Re-filling of syringe with propofol without EDTA</intervention_name>
    <description>Target controlled infusion of propofol (Diprivan®-Astra Zeneca) using equipment Diprifusor® (Astra Zeneca) with re-filling of syringe with propofol not containing EDTA.</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age eighteen years old or more

          -  ASA Physiological Status P1 ou P2

          -  Patients undergoing clean procedure under general anesthesia.

        Exclusion Criteria:

          -  Patients under eighteen years old

          -  ASA Physiological Status P3, P4 or P5

          -  Current infectious process
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Maria Jose C Carmona, Professor</last_name>
    <phone>55-11-3069-5367</phone>
    <email>maria.carmona@incor.usp.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jose Otavio C Auler Jr, Full Professor</last_name>
    <phone>55-11-3069-5232</phone>
    <email>auler@hcnet.usp.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universidade de Sao Paulo Hospital das Clinicas</name>
      <address>
        <city>Sao Paulo</city>
        <zip>05403-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Jansson JR, Fukada T, Ozaki M, Kimura S. Propofol EDTA and reduced incidence of infection. Anaesth Intensive Care. 2006 Jun;34(3):362-8. Review.</citation>
    <PMID>16802492</PMID>
  </reference>
  <reference>
    <citation>Fukada T, Ozaki M. Microbial growth in propofol formulations with disodium edetate and the influence of venous access system dead space. Anaesthesia. 2007 Jun;62(6):575-80.</citation>
    <PMID>17506735</PMID>
  </reference>
  <reference>
    <citation>Trépanier CA, Lessard MR. Propofol and the risk of transmission of infection. Can J Anaesth. 2003 Jun-Jul;50(6):533-7. English, French.</citation>
    <PMID>12826541</PMID>
  </reference>
  <reference>
    <citation>Bennett SN, McNeil MM, Bland LA, Arduino MJ, Villarino ME, Perrotta DM, Burwen DR, Welbel SF, Pegues DA, Stroud L, et al. Postoperative infections traced to contamination of an intravenous anesthetic, propofol. N Engl J Med. 1995 Jul 20;333(3):147-54.</citation>
    <PMID>7791816</PMID>
  </reference>
  <verification_date>September 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 22, 2008</study_first_submitted>
  <study_first_submitted_qc>September 22, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 23, 2008</study_first_posted>
  <last_update_submitted>September 22, 2008</last_update_submitted>
  <last_update_submitted_qc>September 22, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 23, 2008</last_update_posted>
  <responsible_party>
    <name_title>Jose Otavio Costa Auler Jr. / Full Professor Department of Anesthesiology</name_title>
    <organization>Universidade de Sao Paulo</organization>
  </responsible_party>
  <keyword>Propofol</keyword>
  <keyword>Bacterial growth</keyword>
  <keyword>Fungal growth</keyword>
  <keyword>EDTA</keyword>
  <keyword>Target controlled infusion</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Edetic Acid</mesh_term>
    <mesh_term>Pentetic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

